Image

Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer Treatment

Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer Treatment

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

After 1 year, more than 50% experience upper limb (UL) complaints after treatment for breast cancer. These complaints are disabling and cause limitations in daily life and this leads to a decrease in the patient's quality of life. The cause of these UL complaints is complex and multifactorial. Due to breast cancer treatment, the structural (tissue composition and volume) and mechanical (tissue stiffness) properties of the soft tissue may change. These changes can occur in the muscle, skin and surrounding fascia and especially in the soft tissue around the breast and axilla where that treatment is localised.

Ultrasound with specific 'add-on' techniques can objectively assess these features and provide a picture of their role in UL function after breast cancer. The first aim in this study is to investigate the reliability and validity of conventional 2D ultrasound for 1) soft tissue composition and 2) soft tissue thickness at the level of the breast and upper limb. The reliability and validity of shear wave elastography, a specific complement to conventional 2D ultrasound, to assess tissue stiffness will also be examined.

Eligibility

  1. Breast cancer patients without upper limb dysfunctions (n=30) Inclusion Criteria
    • Patients with unilateral primary breast cancer
    • Surgery including, either: Mastectomy with axillary lymph node dissection or sentinel lymph node biopsy or breast conserving surgery with axillary lymph node dissection or sentinel lymph node biopsy
    • At least 3 months after surgery or radiotherapy in order to take into account wound healing
    • Comprehensive of the Dutch language
    • QuickDASH score <15/100

Exclusion Criteria:

  • Bilateral surgery, widespread distance metastases, previous breast surgery
  • Diagnosis of neurological or rheumatological condition
  • upper limb dysfunctions caused by other reasons 2. Breast cancer patients with upper limb dysfunctions (n=30) Inclusion Criteria
  • Patients with unilateral primary breast cancer
  • Surgery including, either: Mastectomy with axillary lymph node dissection or sentinel lymph node biopsy or breast conserving surgery with axillary lymph node dissection or sentinel lymph node biopsy
  • At least 3 months after surgery or radiotherapy in order to take into account wound healing
  • Comprehensive of the Dutch language
  • QuickDASH score >15/100

Exclusion Criteria:

  • Bilateral surgery, widespread distance metastases, previous breast surgery
  • Diagnosis of neurological or rheumatological condition
  • upper limb dysfunctions caused by other reasons 3. Healthy volunteers (n=30)

Inclusion criteria:

  • Healthy women (QuickDASH <15) age-matched with a breast cancer patient from the main study
  • Comprehensive of the Dutch language

Exclusion criteria:

  • upper limb dysfunctions
  • Diagnosis of neurological or rheumatological condition, diabetes

Study details
    Breast Neoplasms

NCT06180642

Universiteit Antwerpen

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.